Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Ryan Deschner's Stock Ratings
Raymond James Analyst
Ryan Deschner is an analyst at Raymond James. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/17/2025
Updated: Dec 17, 2025
Overall Average Return
55.7%
Smart Score
Overall Average Return Percentile
95th
Number of Ratings
22
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/19/2025 | PVLA | Buy Now | Palvella Therapeutics | $96.81 | 47.71% | $92 → $143 | Upgrade | Outperform → Strong Buy | Get Alert | |
| 10/14/2025 | TVRD | Buy Now | Tvardi Therapeutics | $4.26 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/13/2025 | LQDA | Buy Now | Liquidia | $35.26 | 16.28% | $33 → $41 | Maintains | Strong Buy | Get Alert | |
| 08/08/2025 | TRVI | Buy Now | Trevi Therapeutics | $12.41 | 117.57% | $29 → $27 | Maintains | Strong Buy | Get Alert | |
| 08/06/2025 | PVLA | Buy Now | Palvella Therapeutics | $96.81 | -44.22% | → $54 | Initiates | → Outperform | Get Alert | |
| 08/05/2025 | ARDX | Buy Now | Ardelyx | $5.98 | 100.67% | $11 → $12 | Maintains | Outperform | Get Alert | |
| 08/01/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.31 | 97.55% | $52 → $50 | Maintains | Outperform | Get Alert | |
| 07/24/2025 | VKTX | Buy Now | Viking Therapeutics | $35.60 | 242.7% | $125 → $122 | Maintains | Strong Buy | Get Alert | |
| 07/14/2025 | TVRD | Buy Now | Tvardi Therapeutics | $4.26 | 1355.4% | → $62 | Initiates | → Outperform | Get Alert | |
| 05/16/2025 | INZY | Buy Now | Inozyme Pharma | — | — | $15 → $4 | Downgrade | Buy → Hold | Get Alert | |
| 05/09/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.31 | 105.45% | $75 → $52 | Downgrade | Strong Buy → Outperform | Get Alert | |
| 05/09/2025 | LQDA | Buy Now | Liquidia | $35.26 | -17.75% | $27 → $29 | Maintains | Strong Buy | Get Alert | |
| 03/12/2025 | INZY | Buy Now | Inozyme Pharma | — | — | $24 → $12 | Maintains | Outperform | Get Alert | |
| 03/10/2025 | TRVI | Buy Now | Trevi Therapeutics | $12.41 | 133.68% | $9 → $29 | Upgrade | Outperform → Strong Buy | Get Alert | |
| 02/21/2025 | ARDX | Buy Now | Ardelyx | $5.98 | 117.39% | $15 → $13 | Reiterates | Strong Buy → Strong Buy | Get Alert | |
| 01/14/2025 | SPRY | Buy Now | ARS Pharmaceuticals | $10.66 | 162.66% | $26 → $28 | Maintains | Strong Buy | Get Alert | |
| 08/30/2024 | TRVI | Buy Now | Trevi Therapeutics | $12.41 | -27.48% | → $9 | Initiates | → Outperform | Get Alert | |
| 08/19/2024 | LQDA | Buy Now | Liquidia | $35.26 | -23.43% | $27 → $27 | Upgrade | Outperform → Strong Buy | Get Alert | |
| 08/16/2024 | LQDA | Buy Now | Liquidia | $35.26 | -23.43% | → $27 | Initiates | → Outperform | Get Alert | |
| 08/13/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $10.66 | 106.38% | $18 → $22 | Upgrade | Outperform → Strong Buy | Get Alert | |
| 07/25/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $10.66 | 68.86% | → $18 | Initiates | → Outperform | Get Alert | |
| 06/18/2024 | OMGA | Buy Now | Omega Therapeutics | — | — | → $12 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved